COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in ScotlandDelta AY.4.2의 증상이 있는 SARS-CoV-2 감염 및 심각한 COVID-19 결과에 대한 COVID-19 백신 효과: 스코틀랜드의 540만 개인에 대한 코호트 및 테스트 음성 연구Article Published on 2022-07-092022-09-11 Journal: Journal of Global Health [Category] [DOI] 10.7189/jogh.12.05025 PMC 바로가기 [Article Type] Article
Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia사우디아라비아의 건강한 성인을 대상으로 백신 접종 16주 후 SARS-CoV-2 감염에 대한 ChAdOx1 백신 1회 접종 후 결과Article Published on 2022-07-012022-09-11 Journal: Annals of Saudi medicine [Category] [DOI] 10.5144/0256-4947.2022.223 PMC 바로가기 [Article Type] Article
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females남성과 여성에서 ChAdOx1 nCoV-19(AZD1222) 백신에 대한 반응에 대한 탐색적 분석Article Published on 2022-07-012022-09-11 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2022.104128 PMC 바로가기 [Article Type] Article
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID StudyCOVID-19 백신 약화 및 부스터의 효과 및 부작용: ZOE COVID 연구의 전향적 커뮤니티 연구Article Published on 2022-07-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] [DOI] 10.1016/S1473-3099(22)00146-3 PMC 바로가기 [Article Type] Article
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection사전 감염 유무에 관계없이 단일 COVID-19 백신 접종 후 SARS-CoV-2 항체 궤적Article Published on 2022-06-292022-09-12 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-022-31495-x PMC 바로가기 [Article Type] Article
Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency공통 가변성 면역 결핍증에서 2개의 ChAdOx1 nCoV-19 후 BNT162b2 부스팅에 의해 유도된 특정 항체 및 T-세포 반응Article Published on 2022-06-172022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.907125 PMC 바로가기 [Article Type] Article
Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy유지 혈액투석을 받고 있는 말기 신질환 환자에서 코로나19 백신 접종의 면역원성: 혼합 및 일치 전략의 효능Article Published on 2022-06-132022-09-12 Journal: Journal of Korean medical science [Category] [DOI] 10.3346/jkms.2022.37.e180 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial6~17세 어린이 대상 ChAdOx1 nCoV-19(AZD1222) 백신의 안전성 및 면역원성: 2상 단일 맹검, 무작위, 대조 시험인 COV006의 예비 보고서Clinical Trial Published on 2022-06-112022-09-11 Journal: Lancet (London, England) [Category] [DOI] 10.1016/S0140-6736(22)00770-X PMC 바로가기 [Article Type] Clinical Trial
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trialRandomized Controlled Trial Published on 2022-06-092022-10-05 Journal: The Lancet. Respiratory Medicine [Category] [DOI] 10.1016/S2213-2600(22)00163-1 [Article Type] Randomized Controlled Trial
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies칠레의 코로나백 백신 및 부스터 용량에 대한 혈청학적 연구: 항-SARS-CoV-2 스파이크 항체의 면역원성과 지속성Article Published on 2022-06-092022-09-12 Journal: BMC Medicine [Category] [DOI] 10.1186/s12916-022-02406-0 PMC 바로가기 [Article Type] Article